|
MechanismEnvelope glycoprotein gp160 agonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with gp160 x Tubulin
100 Translational Medicine associated with gp160 x Tubulin
0 Patents (Medical) associated with gp160 x Tubulin